HilleVax (NASDAQ:HLVX) Stock, Quote.Headers.trade-ideas

HilleVax

HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.

Gold.goldbar.goldnugget.shutterstock

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

HLVX

MORF

SVMH

WETH

Gold Falls Over 1%; HilleVax Shares Plunge

Wall street sign in New York

Equities

Sector ETFs

Bonds

Broad U.S. Equity ETFs

Upgrades

Forex

Treasuries

Tech

ETFs

$BTC

SPDR Dow Jones Industrial Average ETF Trust

INTC

PARAA

SEDG

U.S. stocks started the week on a neutral note, with the S&amp;P 500 and Nasdaq 100 indices hovering around the flatline by midday trading in New York. This comes after both indices reached fresh record highs last Friday.

Stocks Hold Steady, Small Caps Rise, French Equities Slip After Surprise Win By Left-Wing Bloc: What&#39;s Driving Markets Monday?

Movers

ARHS

BENF

CJET

CLDI

CLEU

DYNT

GRFS

IDYA

IONM

JEWL

KOSS

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

MYNZ

NEGG

NKLA

OPTT

PLSE

Qualigen Therapeutics, Inc. - Common Stock

QLGN

RYDE

SHPW

SIRI

SLRN

UXIN

VIVK

VRPX

ZAPP

Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

HilleVax Inc

Macro Economic Events

Economics

Redbook: US Retail Sales +4.5% Week End Jan 18 vs Year Ago

WIIM

ANIX

Anixa Biosciences shares are trading higher. D Boral Capital maintained a Buy rating on the stock.

Scotiabank analyst Greg Harrison maintains Disc Medicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRON#NASDAQ">IRON</a>) with a Sector Outperform and raises the price target from $70 to $73.

Price Target

Analyst Ratings

IRON

Scotiabank Maintains Sector Outperform on Disc Medicine, Raises Price Target to $73

MDAI

Spectrum AI shares are trading higher after the company provided updates on operating results and anticipates annual revenue exceeding its guidance estimate.

Susquehanna analyst Mehdi Hosseini maintains Seagate Tech Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>) with a Negative and raises the price target from $65 to $68.

Susquehanna Maintains Negative on Seagate Tech Hldgs, Raises Price Target to $68

Textron Inc&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TXT#NYSE">TXT</a>) shares are trading lower after the company <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b43122702/textron-reports-fourth-quarter-2024-results-announces-2025-financial-outlook" rel="noreferrer noopener">reported&nbsp;fourth-quarter&nbsp;results</a>.
Sales grew to&nbsp;$3.613 billion, missing the consensus of&nbsp;$3.81 billion, although adjusted EPS of&nbsp;$1.34 was <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">in line with the consensus</a>.
Textron Aviation&#8217;s revenues stood at&nbsp;$1.3&nbsp;billion, down&nbsp;$242&nbsp;million&nbsp;year-over-year on lower volume and mix of&nbsp;$282&nbsp;million. Textron Aviation&#8217;s backlog came in at&nbsp;$7.8&nbsp;billion.&nbsp;
Bell revenues stood at $1.1 billion, up&nbsp;$58&nbsp;million&nbsp;Y/Y, on higher military and support program revenues of $67 million mainly led by higher volume on the FLRAA program. Bell backlog stood at&nbsp;$7.5 billion.
Industrial revenues stood at&nbsp;$869&nbsp;million&nbsp;(down $92 million&nbsp;Y/Y), owing to lower volume.
For FY24, the operating cash flow of the manufacturing group was&nbsp;$1.0 billion. As of December 28, cash and cash equivalents stood at&nbsp;$1.39 billion.
In the fourth quarter, Textron repurchased shares worth $232 million, resulting in 2024 share repurchases of $1.1 billion.
In December, Textron disclosed a strategic review of its powersports product line within the Industrial segment, leading to the indefinite suspension of production.
Related: <a target="_blank" href="https://www.benzinga.com//node/42558931" rel="noreferrer noopener">Textron Hits The Brakes On Powersports: Strategic Shift Amid Soft Demand</a>
Consequently, the company recorded total pre-tax special charges of $53 million and a $38 million inventory valuation charge in the fourth quarter to write down powersports-related inventory.
FY25&nbsp;Outlook:&nbsp;Textron expects GAAP EPS from continuing operations of&nbsp;$5.19-$5.39&nbsp;or&nbsp;$6.00 -$6.20&nbsp;on an adjusted basis (vs. consensus of&nbsp;$6.42) and revenue of&nbsp;$14.7 billion<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener"> (vs.&nbsp;$14.757 billion&nbsp;estimate)</a>.
Textron projects cash flow from continuing operations of the manufacturing group of&nbsp;$1.2 billion and $1.3 billion.
Scott C. Donnelly, Chairman and CEO, said, &#8220;While a work stoppage at Textron Aviation impacted our 2024 financial results, we saw strong order activity, aftermarket growth, and continued new product development activities with the announcement of the Gen3 family of light jets.&#8221;
&#8220;2024 was a challenging year with a strike at Aviation and difficult end markets in our Industrial segment. Our 2025 outlook of higher revenue and margin reflects a stabilized production line with improved productivity at Textron Aviation, growth across our aerospace and defense businesses driven by new product development, and an improved cost structure at our Industrial segment,&#8221;&nbsp;Donnelly concluded.
Investors can gain exposure to the stock via First Trust Exchange-Traded Fund First Trust Indxx Aerospace &amp; Defense ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MISL#NYSE">MISL</a>) and iShares U.S. Aerospace &amp; Defense ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ITA#BATS">ITA</a>).
Price Action:&nbsp;TXT shares are down 3.63% at $78.25&nbsp;premarket at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/content/42911395/discover-2-under-the-radar-aerospace-stocks-set-for-2025-growth" target="_blank" rel="noreferrer noopener">Discover 2 Under-the-Radar Aerospace Stocks Set for 2025 Growth</a></li>
</ul>

Earnings

Large Cap

Guidance

iShares Dow Jones US Aerospace & Defense Index Fund

MISL

Textron Reports Mixed Q4, Faces Challenges In Aviation And Industrial Segments

OKYO

OKYO Pharma shares are trading higher after the company announced it received $1.4 million in non-dilute funding.

Barclays analyst Matt Miksic maintains Alphatec Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) with a Overweight and raises the price target from $20 to $21.

ATEC

Barclays Maintains Overweight on Alphatec Holdings, Raises Price Target to $21

Roth MKM analyst Rohit Kulkarni downgrades Reddit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) from Buy to Neutral and raises the price target from $116 to $195.

Downgrades

RDDT

Roth MKM Downgrades Reddit to Neutral, Raises Price Target to $195

VINC

Vincerx Pharma shares are trading lower after the company announced it may offer and sell $30 million worth of common stock.

<a href="https://www.globenewswire.com/Tracker?data=QXq3KhPK_8AZgZP0kL1zm4OuPOBpEPdgK_fp2s7wK5bnwXPy3dRd5xP7xTL19DpM477m4sv30hFbPEa6vL3ajvbyFFCBQDbji-UXrcFNXR8=">KULR Technology Group, Inc.</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KULR#NYSE">KULR</a>) (the "Company" or "KULR"), a global leader in carbon-based thermal management and battery safety solutions, has announced an innovative collaboration with the prestigious Scripps Research Institute's Baran Lab. Together, the teams have developed a groundbreaking pyrolytic carbon (PC) electrode material, poised to transform synthetic organic electrochemistry.
The jointly developed electrode is a low-cost, robust, and versatile alternative to traditional amorphous carbon materials such as reticulated vitreous carbon (RVC) and glassy carbon (GC). With unparalleled mechanical strength and reactivity comparable to RVC and GC, this novel PC material overcomes the limitations of cost and scalability that have historically constrained large-scale synthetic organic applications.
Key Advancements:
<ul>
<li>Affordable and Scalable: The pyrolytic carbon electrodes are produced using a proprietary chemical vapor deposition (CVD) process, significantly reducing manufacturing costs and making large-scale synthesis feasible.</li>
<li>Versatile Applications: The material performs exceptionally well across a range of electrochemical reactions, including rapid alternating polarity (rAP) Kolbe couplings, which are essential for high-value chemical production.</li>
<li>Durability and Recyclability: Unlike fragile RVC electrodes, PC electrodes are mechanically robust, enabling simple cleaning and reusability without degradation.</li>
</ul>

KULR

KULR Technology Group And Scripps Research Institute's Baran Lab Develop Cost-Effective Pyrolytic Carbon Electrode For Synthetic Organic Electrochemistry; Enhances Scalability, Versatility In Reactions, And Durability With Proprietary Chemical Vapor Deposition Process

Barclays analyst Kannan Venkateshwar downgrades Rogers Communications (TSX:<a class="ticker" href="https://www.benzinga.com/stock/RCI#TSX">RCI</a>) from Overweight to Equal-Weight and lowers the price target from C$63 to C$39.

TSX:RCI

TSX:RCI/B

Barclays Downgrades Rogers Communications to Equal-Weight, Lowers Price Target to C$39

Xilio Therapeutics shares are trading lower after the company reported initial data from its ongoing Phase 2 clinical trial evaluating vilastobart in combination with atezolizumab.

Goldman Sachs CEO Solomon Says I Don't Think Bitcoin Is A Threat To The U.S. Dollar

RZLV

Rezolve AI Shares Trading Higher; Co Issues Press Release Celebrating Stargate AI Initiative

HUSA

Houston American Energy shares are trading lower after the company announced a $4.42 million registered direct offering.

GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>) will release its fourth-quarter financial results before the <a href="https://www.benzinga.com/quote/GE/earnings">opening bell on Thursday, Jan. 23</a>.
Analysts expect the Ohio-based company to report quarterly earnings at $1.04 per share, up from $1.03 per share in the year-ago period. GE Aerospace projects quarterly revenue of $9.47 billion, compared to $19.42 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Jan. 2, Deutsche Bank analyst Scott Deuschle maintained GE Aero with a Buy rating and lowered the price target from $235 to $228.
With the recent buzz around GE Aerospace, some investors may be eyeing potential gains from the company's dividends. As of now, GE Aerospace offers an annual dividend yield of 0.60%, which is a quarterly dividend amount of 28 cents per share ($1.12 a year).
To figure out how to earn $500 monthly from GE Aerospace, we start with the yearly target of $6,000 ($500 x 12 months).
Next, we take this amount and divide it by GE Aerospace's $1.12 dividend: $6,000 / $1.12 = 3,000 shares.
So, an investor would need to own approximately $1,004,438 worth of GE Aerospace, or 5,357 shares to generate a monthly dividend income of $500.
Assuming a more conservative goal of $100 monthly ($1,200 annually), we do the same calculation: $1,200 / $1.12 = 1,071 shares, or $200,813 to generate a monthly dividend income of $100.
Note that dividend yield can change on a rolling basis, as the dividend payment and the stock price both fluctuate over time.
The dividend yield is calculated by dividing the annual dividend payment by the current stock price. As the stock price changes, the dividend yield will also change.
For example, if a stock pays an annual dividend of $2 and its current price is $50, its dividend yield would be 4%. However, if the stock price increases to $60, the dividend yield would decrease to 3.33% ($2/$60).
Conversely, if the stock price decreases to $40, the dividend yield would increase to 5% ($2/$40).
Further, the dividend payment itself can also change over time, which can also impact the dividend yield. If a company increases its dividend payment, the dividend yield will increase even if the stock price remains the same. Similarly, if a company decreases its dividend payment, the dividend yield will decrease.
GE Price Action: Shares of GE Aerospace gained by 2.5% to close at $187.50 on Tuesday.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43096091/jim-cramer-this-tech-stock-is-a-buy-louisiana-pacific-has-been-a-great-stock">Jim Cramer: This Tech Stock Is A Buy, Louisiana-Pacific Has Been A &#8216;Great Stock&#8217;</a></li>
</ul>

Long Ideas

How To Earn $500 A Month From GE Aerospace Stock Ahead Of Q4 Earnings

USEG

U.S. Energy Corp shares are trading higher. The company announced a public offering of 4,236,000 shares.

Barclays analyst Kannan Venkateshwar downgrades BCE (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BCE#TSX">BCE</a>) from Equal-Weight to Underweight and lowers the price target from C$41 to C$30.

TSX:BCE

Barclays Downgrades BCE to Underweight, Lowers Price Target to C$30

LSTA

Lisata Therapeutics shares are trading lower after the company announced preliminary cohort data from its Phase 2 Ascend trial.

Legal

Press Releases

HilleVax, Inc. (HLVX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HilleVax, Inc. - HLVX

HilleVax Announces Reduction in Force

HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress

HilleVax Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress

Comments

HilleVax

HilleVax (HLVX) Forecast

HilleVax (NASDAQ:HLVX) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga